Gaw. Demunk et al., COMPARISON OF THE IN-VITRO FIBRINOLYTIC-ACTIVITIES OF LOW AND HIGH-MOLECULAR-WEIGHT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, Thrombosis and haemostasis, 70(3), 1993, pp. 481-485
The fibrinolytic activity of low molecular weight (LMW) single-chain u
rokinase-type plasminogen activator (scu-PA) lacking the epidermal gro
wth factor domain and the kringle domain was compared with the activit
y of high molecular weight (HMW) scu-PA. LMW scu-PA was 1-5 times less
active than HMW scu-PA in a fibrin plate method, in a purified fibrin
clot lysis assay and in a plasma clot lysis assay. Time course experi
ments in a chromogenic plasminogen activator assay suggested that LMW
scu-PA was less sensitive to activation by plasmin than HMW scu-PA. Th
is was confirmed in a scu-PA activation test, which showed that at a c
oncentration of 40 IU/ml LMW scu-PA required a three-fold higher plasm
in concentration for 50% activation in 20 min than did HMW scu-PA. Kin
etic experiments in the presence of 0.1 M NaCl showed non-standard Mic
haelis-Menten kinetics for the activation by plasmin of both HMW and L
MW scu-PA. In contrast, standard kinetics was observed at 0.15 M NaCl,
showing a 2.6-fold lower catalytic efficiency for LMW scu-PA than for
HMW scu-PA. It is concluded that the plasmin activation of LMW scu-PA
is about three times slower than the activation of HMW scu-PA. This e
xplains, at least partially, the lower fibrinolytic activity of LMW sc
u-PA in comparison with HMW scu-PA.